Affiliation: Fred Hutchinson Cancer Research Center
- Hockenbery D, Cruickshank S, Rodell T, Gooley T, Schuening F, Rowley S, et al. A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. Blood. 2007;109:4557-63 pubmed..02). The survival benefit was durable to 1 year after randomization. Oral BDP prevents relapses of gastrointestinal GVHD following tapering of prednisone; survival is statistically significantly better among patients receiving BDP. ..
- Hockenbery D. Targeting mitochondria for cancer therapy. Environ Mol Mutagen. 2010;51:476-89 pubmed publisher....